Metabolome in progression to Alzheimer's disease

Mild cognitive impairment (MCI) is considered as a transition phase between normal aging and Alzheimer's disease (AD). MCI confers an increased risk of developing AD, although the state is heterogeneous with several possible outcomes, including even improvement back to normal cognition. We soug...

Descripción completa

Detalles Bibliográficos
Autores principales: Orešič, M, Hyötyläinen, T, Herukka, S-K, Sysi-Aho, M, Mattila, I, Seppänan-Laakso, T, Julkunen, V, Gopalacharyulu, P V, Hallikainen, M, Koikkalainen, J, Kivipelto, M, Helisalmi, S, Lötjönen, J, Soininen, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309497/
https://www.ncbi.nlm.nih.gov/pubmed/22832349
http://dx.doi.org/10.1038/tp.2011.55

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309497/
https://www.ncbi.nlm.nih.gov/pubmed/22832349
http://dx.doi.org/10.1038/tp.2011.55

Ejemplares similares